Women remain at risk of iodine deficiency during pregnancy: The importance of iodine supplementation before conception and throughout gestation by Hynes, KL et al.
nutrients
Article
Women Remain at Risk of Iodine Deficiency during
Pregnancy: The Importance of Iodine
Supplementation before Conception and
Throughout Gestation
Kristen L. Hynes 1,* , Judy A. Seal 2, Petr Otahal 1, Wendy H. Oddy 1 and John R. Burgess 3
1 Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart, TAS 7001, Australia;
Petr.Otahal@utas.edu.au (P.O.); Wendy.Oddy@utas.edu.au (W.H.O.)
2 Public Health Services, Department of Health and Human Services, Tasmanian Government, GPO Box 125,
Hobart, TAS 7001, Australia; Judy.Seal@health.tas.gov.au
3 School of Medicine, University of Tasmania, Private Bag 34, Hobart, TAS 7001, Australia;
j.burgess@utas.edu.au
* Correspondence: K.L.Hynes@utas.edu.au; Tel.: +61-3-6226-7741
Received: 27 November 2018; Accepted: 1 January 2019; Published: 15 January 2019


Abstract: In Australia, pregnant women are advised to take an iodine supplement (I-supp)
(150 µg/day) to reduce risks to the foetus associated with iodine deficiency (ID). To examine the
impact of this recommendation on iodine status, and to identify factors that contribute to adequacy
during gestation, supplement use and Urinary Iodine Concentration (UIC) was measured in 255
pregnant women (gestation range 6 to 41 weeks) in Tasmania. The median UIC (MUIC) of 133 µg/L
(Inter-quartile range 82–233) was indicative of ID, being below the 150–249 µg/L range for adequacy
during pregnancy. Women taking an iodine-containing-supplement (I-supp) had a significantly
higher MUIC (155 µg/L) (n = 171) compared to the combined MUIC (112.5 µg/L) (n = 84) of those
who had never (120 µg/L) (n = 61) or were no longer taking an I-supp (90 µg/L) (n = 23) (p = 0.017).
Among women reporting I-supp use, the MUIC of those commencing the recommended 150 µg/day
prior to conception was significantly higher than those starting supplementation following pregnancy
confirmation: 196 (98–315) µg/L (n = 45) versus 137.5 (82.5–233.5) µg/L (n = 124), p = 0.032. Despite
recommendations for iodine supplementation pregnant Tasmanian women remain at risk of ID.
Commencing an I-supp of 150 µg/day prior to conception and continuing throughout pregnancy is
required to ensure adequacy. Timely advice regarding the importance of adequate iodine nutrition,
including supplementation is needed to reduce the risk of irreversible in utero neurocognitive damage
to the foetus.
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1. Introduction
The risk of endemic iodine deficiency (ID) has been well characterised in the south-eastern
Australian states of New South Wales (NSW), Victoria (VIC) and Tasmania (TAS) [1,2]. To address
public health concerns of inadequate iodine status in Australia and New Zealand mandatory
replacement of salt with iodised salt in bread was introduced in 2009 [3]. A series of urinary iodine
surveys of Tasmanian school-age children, who are used as a proxy for the general population, indicates
that bread fortification has successfully increased iodine status from deficiency to adequacy [4].
However, fortification has had little impact on the status of pregnant women, increasing the
pre-fortification median urinary iodine concentrations (MUIC) from 76 µg/L to 86 µg/L [5], well below
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the World Health Organization (WHO) 150–249 µg/L range for adequacy in pregnancy [6]. Similar
results have been reported elsewhere [7,8].
Adequate iodine nutrition is essential during pregnancy for foeto-maternal production of thyroid
hormones required for optimal foetal neurodevelopment. The consequences of severe iodine deficiency
(ID) include spontaneous abortion, stillbirth, congenital abnormalities and endemic cretinism [6].
Increasing evidence suggests that even transient, mild gestational ID has subtle negative impacts,
including reductions in IQ [9], educational outcomes [10,11] and language skills [12,13].
Dietary iodine requirements rise by approximately 50% during pregnancy, driven by increased
thyroid synthetic demands, increased renal iodine clearance, and transfer of iodine and thyroxine to
the foetus [14]. National Health and Medical Research Council (NHMRC) guidelines recommended
that the daily intake (RDI) of iodine for adolescents and adults increase from 150 µg/day to 220 µg/day
during pregnancy [15]. In regions classified as mildly or borderline deficient, pregnant women may
have difficulty increasing their level of iodine intake to provide sufficient nutrition for the developing
foetus, and pregnant women, and in some cases women of child-bearing age, are iodine deficient
despite the general population being considered sufficient [16,17].
Recognition that the current mandatory bread fortification program alone is insufficient to meet the
increased demand during pregnancy, the NHMRC introduced recommendations in 2010 for pregnant
and breastfeeding women, and women planning pregnancy, to take a daily iodine supplement of
150 µg/day to help meet the 220 µg/day RDI [18]. It advises supplementation “from the point of
planning pregnancy” or “as soon as possible after” confirmation of pregnancy, with supplementation
continuing throughout pregnancy and breastfeeding.
We report the iodine status of a group of pregnant Tasmanian women following the introduction
of mandatory bread fortification and recommendations for iodine supplementation, and discuss factors
contributing to adequate iodine nutrition during gestation.
2. Materials and Methods
WHO sentinel surveillance techniques, employed globally to assess and monitor iodine nutrition
within populations [6], were used. A convenience sample of pregnant women residing in the southern
Tasmanian region were recruited at Royal Hobart Hospital antenatal clinics, and via social media and
conventional advertising, as part of a larger investigation (Tasmanian Women’s Iodine Nutrition
Knowledge (TWINK) Study). Women at all stages of gestation were eligible. To ascertain the
iodine status of women of reproductive age, a representative sample of women residing in the
same local government areas as the pregnancy group were selected from the Tasmanian electoral
roll. Non-pregnant, non-lactating women were eligible. Participants provided a spot urine sample
for urinary iodine concentration (UIC) assessment and completed a questionnaire on enrolment.
Use and dose of dietary supplements containing iodine (I-supp) during pregnancy and prior to
conception was recorded. As retrospective recording of the precise time that supplementation was
started is subject to recall bias, iodine supplementation start time is reported dichotomously as “Before”
and “After” conception. In Australia, a large variety of over-the-counter nutritional supplements
containing iodine are available in tablet, capsule and liquid form, including supplements marketed
specifically for pre-conception, pregnancy and lactation, as well as many multi-vitamin formulations
that include iodine. Differences in the active amount of iodine and dosage recommendations result in
a range of recommended daily doses. To determine compliance with the NHMRC recommendation
of 150 µg/day [18], participants were asked to provide information on the brand and the daily dose
of all nutritional supplements they were taking. At the end of the enrolment visit each participant
was provided with a copy of the 2010 NHMRC recommendations for iodine supplementation during
pregnancy. Additional spot urine samples and information on I-supp use was collected during each
remaining trimester. To determine the median UIC in this sample of women, only data collected at
enrolment is reported here as it is probable that provision of the NHMRC recommendations, and
indeed participation in the study, led to changes in behaviour with regard to supplement use and
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intake of iodine from dietary sources. Inclusion of samples collected after enrolment could give a false
indication of the median UIC in this sample.
UIC was determined at the Institute of Clinical Pathology and Medical Research (Westmead
Hospital, Sydney, Austrilia), which complies with IOS/IEC standard 17025, using the modified
Sandell-Kolthoff reaction. Iodine status was defined using WHO classifications [6], where a MUIC
between 150–249 µg/L during pregnancy is adequate; and general population adequacy is classified
as a MUIC between 100–199 µg/L, with less than 20% below 50 µg/L.
Stata/SE 15.1 (StataCorp LLC, College Station, TX, USA) was used for statistical analysis. UIC is
skewed, thus median and interquartile range (IQR) are presented. Means and standard deviations (SD)
are used for continuous measures and percentages for categorical measures. p-Values were calculated
using two-sample Mann-Whitney test of difference between MUIC for two groups, and Krushal-Wallis
equality of populations rank test for three or more groups.
The study was approved by the Tasmanian Health and Medical Human Research Ethics
Committee (#H0013336) and participants gave informed written consent.
3. Results
3.1. Iodine Status of Pregnant Women
Two-hundred and fifty-five pregnant women were recruited between March 2014 and November
2015. The MUIC at enrolment was 133 (IQR 82-233) µg/L (Table 1). MUIC was highest in the group of
women who enrolled during the first trimester and lowest in the group of women who enrolled in the
third trimester with the third trimester MUIC being significantly lower than the first (161 vs. 119 µg/L,
p = 0.046).
Table 1. Characteristics of pregnant women (n = 255) at enrolment and associated group median
urinary iodine concentration (MUIC).
Characteristic Mean (Standard Deviation) andRange, or Percentage (n/N) MUIC
1 (IQR) µg/L p-Value 2
All participants 133 (82–233)
Age (years) 29.3 (6.0) 15–45
Gestational Age (weeks) 21.1 (8.3) 6–41
Trimester:
T1 (0–13 weeks) 16.5% (42/255) 161 (92–233)
T2 (14–26 weeks) 56.5% (144/255) 137.5 (81.5–243)
T3 (≥27 weeks) 27.0% (69/255) 119 (78–185) 0.115
Highest Level of Education Completed:
Year 10 or less 19.8% (50/253) 137.5 (82–247)
>Year 10 80.2% (203/253) 129 (82–233) 0.851
First Pregnancy:
Yes 36.0% (91/253) 111 (79–222)
No 64.0% (162/253) 140 (86–236) 0.206
Intention to breastfeed:
Yes 89.6% (223/249) 121 (87–233)
No 10.4% (26/249) 133 (81–235) 0.765
Previous miscarriage:
Yes 31.4% (77/245) 122 (81–235)
No 68.6% (168/245) 137.5 (82.5–231.5) 0.793
Number of Children
(excluding current pregnancy):
0 43.3% (106/245) 112 (79–222)
1 33.1% (81/245) 140 (83–243)
2 16.3% (40/245) 152 (87.5–226)
3–6 7.4% (18/245) 175.5 (95–398) 0.455
1 MUICs within the adequate range (150–249 µg/L) are shown in bold; 2 p-values for Two-sample Mann-Whitney
test of difference in UIC between two groups, or Krushal-Wallis equality of populations rank test for difference in
UIC for three or more groups.
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3.2. Iodine Supplement Use
Two-thirds (n = 171) of participants, were taking an I-supp at enrolment, with 149 (87%) of these
taking the recommended dose of 150 µg/day or more (Table 2). The mean daily dose of iodine from
supplements was 178 (SD 67.4) µg/day and ranged between 43 to 500 µg/day. The percentage of
participants using an I-Supp at enrolment was similar across all trimesters, with only a small decline
in use from the first to the third trimester.
Table 2. Iodine status of pregnant Tasmanian women categorised by iodine supplement use, dose and
timing, and trimester at enrolment. Defined by median urinary iodine concentration (MUIC) and by
percentage and number <150 µg/L.
Category MUIC 1 (IQR) µg/L p-Value 2 % <150 µg/L 3 (n)
All participants (n = 255) 133 (82–233) 55.3% (141)
I-Supp Use:
Never (n = 61) 120 (79–207) 65.6% (40)
Ever (n = 194) 135 (85–235) 0.208 52.1% (101)
No longer taking (n = 23) 90 (70–151) 73.9% (17)
Still taking (n = 171) 155 (86–247) 0.020 49.1% (84)
Among those still taking an I-supp (n = 171)
Dose 4:
<150 µg/day (n = 20) 104 (80.5–243.5) 55.0% (11)
=150 µg/day (n = 93) 153 (90–233) 49.5% (46)
>150 µg/day (n = 56) 182 (86–303) 0.350 5 44.6% (25)
Timing:
After Conception (n = 123) 135 (82–234) 52.0% (64)
Before Conception (n = 48) 193 (97.5–314.5) 0.046 41.7% (20)
Dose 4 and Timing:
After Conception & <150 (n = 18) 104 (78–304) 55.6% (10)
After Conception & ≥150 (n = 104) 140 (84–233.5) 51.0% (53)
Before Conception & <150 (n = 2) 131 (95–167) 50.0% (1)
Before Conception & ≥150 (n = 45) 196 (98–315) 0.032 6 40.0% (18)
By Trimester:
I-supp started After Conception (n = 123):
T1 (0–13 weeks) (n = 21) 184 (100–235) 33.3% (7)
T2 (14–26 weeks) (n = 71) 158 (81–244) 49.3% (35)
T3 (≥27 weeks) (n = 31) 98 (77–161) 0.068 71.0% (22)
I-supp started Before Conception (n = 48):
T1 (0–13 weeks) (n = 9) 144 (85–209) 55.6% (5)
T2 (14–26 weeks) (n = 27) 221 (114–373) 33.3% (9)
T3 (≥27 weeks) (n = 12) 162.5 (86–266) 0.329 50.0% (6)
1 Median urinary iodine concentration (MUIC) and Interquartile Range (IQR) reported. MUICs within the adequate
range shown in bold; 2 p-values for Two-sample Mann-Whitney test of difference in UIC between two groups, or
Krushal-Wallis equality of populations rank test for difference in UIC for three groups. p-Values less than 0.05
are shown in bold; 3 Refers to the percentage (and number) of participants with a UIC less than 150 µg/L; 4 Dose
information unavailable for n = 2 participants; 5 For Dose, the groups compared are <150 and ≥150 (i.e., =150 and
>150 combined); 6 For Dose and Timing, the groups compared are the last category (Before Conception & ≥150) vs.
the first three categories combined (MUIC 137.5 (82.5–233.5)) (i.e., After Conception & <150; After Conception &
≥150, and; Before Conception & <150).
Those women still taking an I-supp at enrolment had a higher iodine status (155 µg/L, n = 171)
than those who had never (120 µg/L, n = 61), or were no longer taking an I-supp (90 µg/L n = 23);
the combined MUIC of these groups was indicative of ID (112.5 (77–190.5) µg/L, n = 84) and was
significantly lower than the group still taking an I-supp (p = 0.017).
Among those still taking an I-supp, only those who started before conception, and took the
recommended dose of 150 µg/day, or greater, attained adequacy. The MUIC of this group (196 (98–315)
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µg/L, n = 45) was significantly higher than that of the other three dose and timing groups combined
(137.5 (82.5–233.5) µg/L, n = 124, p = 0.032).
Comparing those still taking I-supps, the decline observed in MUIC across trimesters was only
evident among those who started an I-supp post-conception. In this group, the third trimester MUIC
was significantly lower than the first trimester (184 vs. 98 µg/L, p = 0.032). Among those who took an
I-supp prior to conception, the MUIC did not decline, but remained close to or within the adequate
range throughout pregnancy.
3.3. Iodine Status of Non-Pregnant/Non-Lactating Women of Reproductive Age
Sixty-three non-pregnant, non-lactating women, aged 21–50 years, participated. Their MUIC
was 79 (48–135) µg/L; 27.0% (17/63) were <50 µg/L, with 31.8% (20/63) between 100–199 µg/L, and;
81.0% (51/63) were <150 µg/L. The MUIC of women taking an I-supp (n = 10) fell within the adequate
range, 104.5 (84–152) µg/L, but was not significantly higher than those who did not take an I-supp
(73 (45–124) µg/L n = 53, p = 0.214).
4. Discussion
Our results indicate Tasmanian women continue to be at risk of ID in pregnancy. However,
we show that iodine supplementation consistent with NHMRC recommendations [18] can improve
iodine nutrition, with our findings underscoring the importance of pre-conception supplementation
for ensuring adequacy throughout pregnancy.
ID has also been reported in pregnant women (MUIC 116 µg/L) across Australia in the 2011–2012
National Health Measures Survey (NHMS) [19]. By contrast, studies in some states have reported
MUICs within, or close to, the adequate range (NSW 145.5 µg/L in 2011 and 166 µg/L in 2012 [20]; SA
between 172 and 189 µg/L in 2011–2012 [21]). To understand the variation in MUICs in different areas
of Australia, consideration must be given to factors influencing iodine status, including differences in
consumption of iodine-containing foods, I-supp use, gestational stage, underlying population iodine
status (particularly in women of reproductive age) and pre-conception thyroid stores.
In Tasmania, we have previously shown that bread fortification has little impact on pregnancy
iodine status [5]. This study indicates that iodine supplementation can improve iodine nutrition
to adequate levels. While the overall status of our sample was indicative of ID, women taking
supplements in accordance with recommendations were within the adequate range. By contrast,
women not taking supplements, whether pregnant or not, had MUICs comparable to those reported
in pregnant women surveyed prior to the supplementation recommendations (86 µg/L) [5]. Other
Australian studies report similar results. In two NSW [20] cohorts, MUICs were higher among women
taking I-supps compared to those who didn’t (178 and 202 µg/L vs. 109 and 124 µg/L, respectively).
In SA [21], higher MUICs, at two gestational time-points, were reported in women taking supplements
(152 and 221 µg/L) compared to those who didn’t (141 and 159 µg/L).
Taking I-supps, however, does not guarantee sufficiency during pregnancy. A NSW study
conducted prior to fortification and supplementation recommendations, reported higher, but
less than adequate, MUIC among women taking I-supps compared to those not (115 and
72 µg/L, respectively) [22]. Similarly, studies in VIC [7] and SA [8], spanning the pre/post
fortification/supplementation periods, found higher but still inadequate MUICs among those taking
I-supps compared to those who didn’t (VIC: 121.5 and 64.5 µg/L; SA: 89 and 75 µg/L).
Not all groups taking I-supps reached sufficiency in our study; current I-supp consumption
and dose were important predictors of adequacy. Only women still taking an I-supp at enrolment
had a MUIC within the adequate range. Among those that had ceased supplementation there was
no evidence of any enduring I-supp consumption effect on current iodine status, highlighting the
importance of recent intake for maintenance of adequate nutrition and supporting the NHMRC
recommendation for daily supplementation throughout pregnancy. We found evidence of a
dose-response, with increased levels of supplementation associated with higher MUICs. In accord with
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the NHMRC recommendation, only those taking the suggested daily amount of 150 µg/day, or above,
reached adequacy. By contrast, groups that had never or were no longer taking an I-supp had MUICs
indicative of ID. Condo et al. [21] also report a positive dose-response; MUICs at two gestational
time-points were higher in women taking ≥150 µg/day compared to those taking <150 µg/day
(<20 weeks: 221 vs. 163 µg/L, and; 28 weeks: 187 vs. 152 µg/L). Unlike our study, both dose groups
had MUICs within the adequate range.
The dose of I-supps required to assist women reach sufficiency for pregnancy will be influenced
by the underlying iodine nutrition of the population. The lower the dietary intake of iodine from food
sources, the greater the level of supplementation required. Surveys of school-age children indicate
that mandatory fortification has led to adequate iodine nutrition levels in Tasmania [4]. While the
NHMRC asserts that “through mandatory fortification, most of the Australian population will get
enough iodine, meaning women of child-bearing age should enter pregnancy with adequate thyroid
stores” [18], our data for Tasmanian women of reproductive age indicates this may not be the case.
Applying 100 µg/L general population adequacy cut-point, the 79 µg/L MUIC with 27.0% <50 µg/L
is indicative of ID, suggesting that women may be entering pregnancy with sub-optimal thyroid stores.
While it can be argued that adult UICs between 60–70 µg/L are equivalent to 100 µg/L in children,
due to larger urinary volume outputs in adults [23], we suggest that UICs at this level ill-prepare
women entering pregnancy for the increased iodine requirements of gestation. Our finding is similar
to national data, where women of child-bearing age in the 2011–2012 NHMS [19,24] had lower iodine
levels than children and other adults. Although the MUICs (Australia 121 µg/L; Tasmania 105 µg/L)
were within the adequate range for non-pregnant/non-breastfeeding women, the report [24] raised
concerns that mandatory fortification may not be meeting the needs of women of child-bearing age.
Concerningly, 18.3% of women across Australia had UICs <50 µg/L, which approaches the 20%
cut-point indicative of insufficient iodine intake.
Further evidence that Tasmanian women are entering pregnancy with inadequate thyroid stores
is provided by the changes in MUIC as pregnancy progresses. Studies show that UICs, which increase
early in pregnancy, follow two patterns as pregnancy progresses, depending upon the underlying
population iodine status [25]. In populations where ID exists MUICs in the 2nd and 3rd trimesters
decline, often falling below adequate levels. The decline is less marked in iodine sufficient populations
with MUICs usually remaining within the optimal range throughout gestation. The pattern observed
in our study is indicative of a population with inadequate iodine nutrition. However, among the
small number of women who began supplementation prior to conception no decline was evident, with
MUICs remaining adequate across trimesters. These observations support the notion that adequate
pre-conception thyroid stores, whether attained via iodine from foods, I-supps, or a combination, are
essential for maintaining iodine levels throughout pregnancy.
Women in our study who started supplementation after pregnancy did not maintain adequate
levels as gestation progressed, suggesting that although supplementation after pregnancy improves
UICs, it may not be enough to replenish or maintain thyroid stores that are inadequate prior to
conception. A recent UK study found that inadequate pre-conception iodine status (MUIC 108.4 µg/L,
17.8% <50 µg/L) was positively associated with poorer cognitive function in the offspring [26]. Given
many pregnancies are unplanned, and women may be unaware until well into the first trimester, it
is vital that women of child-bearing age have adequate pre-conception iodine nutrition to ensure
adequacy for foetal neurodevelopment in early gestation. In populations where iodine intake from
dietary sources is inadequate, pre-conception supplementation may improve thyroid stores prior
to pregnancy.
Adequate dietary iodine preconception is also important for maintenance of pregnancy, with
miscarriage rates known to be higher in regions of severe iodine deficiency [27]. While we found no
significant difference in the MUIC of women who had previously had a miscarriage compared to
those who had not, the percentage of women (31.4%) reporting ever having had a miscarriage was
higher than expected (up to 25%) in Australia [28]. While it is beyond the scope of this study to explain
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the high level of miscarriage in our sample, the long-standing existence of iodine deficiency in the
Tasmanian population may be an important factor. However, it is not unreasonable to expect some
recruitment bias in our sample, with women who have previously had an unexpected outcome in
pregnancy being more likely to participate in a study of pregnancy knowledge, because of a heightened
interest fuelled by their past experience.
Our study has some limitations. To obtain precise group MUICs from spot urine samples,
approximately 125 samples are required to estimate iodine levels with 95% confidence and ±10%
precision [29]. Although our results are consistent with other studies, care must be taken when
interpreting MUICs of small sub-groups. Furthermore, although it is appropriate to use spot samples
to determine the median value of a group, UIC is not ideal for classifying individuals, as a single
sample may not be indicative of usual status. UIC can vary day-to-day depending upon dietary intake,
and while a spot sample reflects ingested iodine over the past 24-h, it can be influenced by circadian
rhythm and post-meal peaks [30]. For use as an individual measure a minimum of 10 samples are
recommended [29,31]. Although women in our study provided samples each trimester it was not
feasible to collect more and given the confounding effects of gestational stage on UIC taking the average
over trimesters is not advisable. Lack of a gold-standard measure of individual status means caution
must be exercised when results derived from techniques designed for assessing populations are used
to develop public health advice for individuals. Caution is also advised regarding the generalisability
of our findings to all pregnant women in Tasmania, or elsewhere in Australia, as recruitment of a
volunteer sample may result in selection bias and lack of representativeness. Although our research
has previously shown no link between measures of socio-economic status and iodine nutrition [32],
our sample was slightly younger than the average pregnant women in Australia (29.3 versus 30.3
years [33]) and more likely to have completed schooling beyond Year 10 compared to Tasmania women
of childbearing age [34].
Despite these limitations, it is concerning that in our sample only a small percentage of individuals
had UICs within the adequate range. While a single UIC may not indicate usual status, even transient
inadequate iodine consumption during pregnancy can have detrimental impacts on the fast-developing
foetus. We have demonstrated that even mild maternal ID, defined as a UIC <150 µg/L at one point
during pregnancy, is associated with deficits in educational outcomes that persist into adolescence [11].
Globally, epidemiological studies have linked transient maternal hypothyroidism at crucial times of
foetal neurodevelopment to impaired cognitive [9] and psychomotor development [35], behavioural
difficulties [36], and abnormal brain morphology [37], with a recent meta-analysis also suggesting
that maternal hypothyroxinemia during gestation is associated with lower non-verbal and verbal
IQ in the offspring [38]. A randomised controlled trial is needed to facilitate a rigorous examination
of the impact of I-supps given a Cochrane review of past trials found “ . . . there was insufficient
data for any meaningful conclusions on the benefits and harms of routine iodine supplementation in
women before, during or after pregnancy” [39]. Despite an absence of more robust measures, our study
adds to a growing body of evidence suggesting that, even in regions classified as iodine sufficient,
women may remain at risk of gestational ID if their intake is inadequate prior to conception and they
don’t supplement throughout pregnancy. Education about iodine nutrition and the current NHMRC
recommendations for supplementation before and during pregnancy to reduce the risk of irreversible
long-term, yet preventable, impacts of gestational ID on offspring is needed.
5. Conclusions
Despite the introduction of public health measures to address ID in Australia, including
mandatory fortification of bread with iodised salt and a recommendation for daily iodine
supplementation prior to and throughout pregnancy and breastfeeding, our study indicates that
women continue to be at risk of ID during pregnancy. Adequate iodine status was only observed among
women who commenced iodine supplementation at the recommended dose prior to conception and
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continued throughout pregnancy. Timely advice about adequate maternal iodine nutrition, including
supplementation, is necessary to reduce the risk of neurocognitive damage to the foetus.
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